- Home
- / enGene
enGene
Stock Price
$9
2024-10-29
Market Capitalization
$397.9 M
2024-10-29
enGene Summary
Company Summary
- Overview
- enGene is a biotechnology company developing a non-viral vector platform to deliver genes to mucosal cells lining the gut.
- Type
- Public
- Status
- Active
- Founded
- 1999
- HQ
- Montréal, CA | view all locations
- Website
- https://engene.com/
- Cybersecurity rating
Table of Contents
Key People
Alex Nichols, President & Chief Operating Officer
Anthony T. Cheung, Co-Founder & Chief Technology Officer
James C. Sullivan, Chief Scientific Officer
LocationsView all
2 locations detected
Montréal, QC HQ
Canada
4868 Rue Levy #220
Waltham, MA
United States
200 5th Ave #4020
enGene Financials
Summary Financials
- Net income (Q1, 2026)
- ($29.8M)
- Cash (Q1, 2026)
- $36.6M
- EBIT (Q1, 2026)
- ($31.8M)
- Enterprise value
- $386.3M